Protective effect of potassium against the hypertensive cardiac dysfunction: association with reactive oxygen species

Hiromitsu Matsui1, Tatsuo Shimosawa, Yuzaburo Uetake

  • 1Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo, Japan.

Insights

High potassium intake protects against heart dysfunction in salt-sensitive rats by reducing cardiac NADPH oxidase activity. This protective effect on left ventricular relaxation is independent of blood pressure changes.

Area of Science:

  • Cardiovascular Physiology
  • Renal and Electrolyte Physiology

Background:

  • Potassium plays a role in cardiovascular health, but its precise mechanism in preventing early cardiac alterations in hypertension is unclear.
  • Hypertension, particularly salt-sensitive hypertension, is associated with impaired left ventricular relaxation and increased oxidative stress.

Purpose of the Study:

  • To investigate the protective effects of potassium against salt-induced cardiac dysfunction in Dahl salt-sensitive rats.
  • To elucidate the underlying mechanisms, focusing on cardiac NADPH oxidase activity and its role in left ventricular relaxation.

Main Methods:

  • Dahl salt-sensitive rats were fed normal or high-salt diets, with or without high potassium or a superoxide dismutase mimetic.
  • Left ventricular relaxation was assessed using Doppler transmitral inflow, pressure curve slope, and isovolumic relaxation time constant.
  • Cardiac NADPH oxidase activity was measured using the lucigenin chemiluminescence method.

Main Results:

  • High-salt diet elevated blood pressure and impaired left ventricular relaxation, associated with increased cardiac NADPH oxidase activity.
  • Hydralazine lowered blood pressure but did not improve cardiac function or reduce NADPH oxidase activity.
  • Potassium supplementation and superoxide dismutase mimetic treatment improved left ventricular relaxation and reduced NADPH oxidase activity, despite sustained high blood pressure.

Conclusions:

  • High-potassium diets protect against left ventricular relaxation impairment in salt-sensitive hypertension, independent of blood pressure reduction.
  • This protection is partly mediated by the inhibition of cardiac NADPH oxidase activity.
  • Potassium supplementation is a promising strategy for cardiac protection in hypertensive individuals, especially those sensitive to salt.

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...